MIT Sloan logo MIT logo

Research


Bridging the Valley of Death through Financial Innovation

2019

Risk and Reward in the Orphan Drug Industry

2019
The Journal of Portfolio Management
Richard Thakor

A Portfolio Approach to Accelerate Therapeutic Innovation in Ovarian Cancer

2019
The Journal of Investment Management
Shomesh Chaudhuri, Katherine Cheng, Shirley Pepke, Sergio Rinaudo, Lynda Roman, and Ryan Spencer

Machine Learning with Statistical Imputation for Predicting Drug Approvals

2019
Harvard Data Science Review
Kien Wei Siah and Chi Heem Wong

Acceleration of rare disease therapeutic development: a case study of AGIL-AADC

2019
Drug Discovery Today
Sonya Das, Samuel Huang

Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design

2019
Journal of Econometrics
Leah Isakov and Vahid Montazerhodjat

New Business Models to Accelerate Innovation in Pediatric Oncology Therapeutics A Review

2018
JAMA Oncology
Sonya Das, Raphael Rousseau, Peter C. Adamson

Patient-centered clinical trials

2018
Drug Discovery Today Volume 23, Issue 2, February 2018, Pages 395-401
Shomesh E. Chaudhuri,  Martin P. Ho, Telba Irony, and Murray Sheldon

Estimation of clinical trial success rates and related parameters

2018
Biostatistics (2018) 00, 00, pp. 1–14
Chi Heem Wong, Kien Wei Siah

Pricing for Survival in the Biopharma Industry: A Case Study of Acthar Gel and Questcor Pharmaceuticals

2017
Journal of Investment Management
Terence C. Burnham and Samuel Huang

© 2020 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.